These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8457637)

  • 21. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locating the active site for angiogenesis and cell proliferation due to fibrin fragment E with a phage epitope display library.
    Stirk CM; Reid A; Melvin WT; Thompson WD
    Gen Pharmacol; 2000 Nov; 35(5):261-7. PubMed ID: 11888682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations between plasma levels of fibrin(ogen) derivatives as quantified by different assays based on monoclonal antibodies.
    Kroneman H; Nieuwenhuizen W; Knot EA; Van Bergen PF; De Maat MP
    Thromb Res; 1991 Feb; 61(4):441-52. PubMed ID: 1953861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?
    van Bergen PF; Knot EA; Jonker JJ; de Boer AC; de Maat MP
    Thromb Haemost; 1989 Dec; 62(4):1043-5. PubMed ID: 2694421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
    Alkjaersig N; Davies A; Fletcher A
    Thromb Haemost; 1977 Aug; 38(2):524-5. PubMed ID: 145666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure.
    Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemostatic imbalance in active and quiescent ulcerative colitis.
    van Bodegraven AA; Schoorl M; Baak JP; Linskens RK; Bartels PC; Tuynman HA
    Am J Gastroenterol; 2001 Feb; 96(2):487-93. PubMed ID: 11232695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor.
    Shing Y; Folkman J; Haudenschild C; Lund D; Crum R; Klagsbrun M
    J Cell Biochem; 1985; 29(4):275-87. PubMed ID: 2418039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preparation and separation of milligram amounts of canine fibrin(ogen) degradation products (fdp) X, Y, D and E].
    Wolling H; Mischke R
    Berl Munch Tierarztl Wochenschr; 1995 Nov; 108(11):421-6. PubMed ID: 8593135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
    Marder VJ; Cruz GO; Schumer BR
    Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of bound thrombin consisting of thrombin and fibrin N-terminal fragment from clot lysate.
    Kinjoh K; Nakamura M; Sunagawa M; Kosugi T
    Haematologia (Budap); 2002; 32(4):457-65. PubMed ID: 12803119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinogen fragments X, Y, D and E increase levels of plasma fibrinogen and liver mRNAs coding for fibrinogen polypeptides in rats.
    Princen HM; Moshage HJ; Emeis JJ; de Haard HJ; Nieuwenhuizen W; Yap SH
    Thromb Haemost; 1985 Apr; 53(2):212-5. PubMed ID: 4024030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitogenic activity in human atherosclerotic lesions.
    Thompson WD; McGuigan CJ; Snyder C; Keen GA; Smith EB
    Atherosclerosis; 1987 Jul; 66(1-2):85-93. PubMed ID: 3632755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE; Cajthamlová H; Suttnar J
    Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.